If all goes well, the company will have a drug on the market that could bring in billions of dollars in revenue.Vera Therapeutics (VERA +13.25%) was a standout in the biotech sector on Wednesday. Its stock closed that trading session 13% higher, thanks in no small part to a bullish new note published by an analyst that morning. A huge potential marketThe prognosticator behind the positive note was Cantor Fitzgerald's Pete Stavropoulos, who reiterated his existing overweight (read: buy) recommendation and $1 ...